ID   HN-6Rr
AC   CVCL_A1TJ
SY   LICR-LON-HN6-R; LICR (Lond) HN-6Rr
DR   Wikidata; Q105507702
RX   PubMed=2183872;
RX   PubMed=7284233;
CC   Doubling time: 30 hours (PubMed=7284233).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8129 ! HN-6
OI   CVCL_EJ03 ! HN-6n1
OI   CVCL_A1TI ! HN-6n2
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=2183872; DOI=10.1038/bjc.1990.80; PMCID=PMC1971288;
RA   Rumsby G., Carter R.L., Gusterson B.A.;
RT   "Low incidence of ras oncogene activation in human squamous cell
RT   carcinomas.";
RL   Br. J. Cancer 61:365-368(1990).
//
RX   PubMed=7284233; DOI=10.1038/bjc.1981.193; PMCID=PMC2010768;
RA   Easty D.M., Easty G.C., Carter R.L., Monaghan P., Pittam M.R.,
RA   James T.;
RT   "Five human tumour cell lines derived from a primary squamous
RT   carcinoma of the tongue, two subsequent local recurrences and two
RT   nodal metastases.";
RL   Br. J. Cancer 44:363-370(1981).
//